PCR-based assays for detection of Streptococcus pneumoniae serotypes 3, 14, 19F and 23F in respiratory specimens

Lorry G Rubin1, Atqia Rizvi1

  • 1Schneider Children's Hospital of the North Shore-Long Island Jewish Health System, 269-01 76th Ave, New Hyde Park, NY 11040, USA.

Insights

New PCR assays detect multiple Streptococcus pneumoniae serotypes in respiratory samples. These sensitive and specific molecular tests improve upon culture-based methods for identifying pneumococcal colonization.

Area of Science:

  • Molecular Microbiology
  • Bacterial Pathogenesis
  • Diagnostic Assay Development

Background:

  • Culture-based methods are insufficient for detecting multiple Streptococcus pneumoniae serotypes simultaneously.
  • Pneumococcal serotypes 3, 14, 19F, and 23F are significant causes of respiratory infections.
  • Accurate identification of pneumococcal serotypes is crucial for epidemiological surveillance and treatment.

Purpose of the Study:

  • To develop and evaluate sensitive and specific single-tube, nested PCR-based assays for detecting Streptococcus pneumoniae serotypes 3, 14, 19F, and 23F.
  • To assess the performance of these assays compared to traditional culture methods.
  • To determine the utility of PCR assays for identifying pneumococcal serotypes directly from respiratory tract specimens.

Main Methods:

  • Design of outer and inner primers and probes targeting unique DNA sequences in the capsular polysaccharide gene cluster of specific pneumococcal serotypes.
  • Optimization of PCR conditions for amplifying and detecting target sequences.
  • Validation of assay sensitivity and specificity using known DNA quantities and clinical isolates, including testing on human throat swabs.

Main Results:

  • PCR assays demonstrated high sensitivity, detecting as little as 0.01 fg of chromosomal DNA or DNA from one viable bacterial cell.
  • Each serotype-specific assay accurately identified homologous strains and showed no cross-reactivity with other pneumococcal serotypes or non-pneumococcal bacteria.
  • Testing on clinical throat swabs showed concordance with culture results for positive samples and identified potential true positives in culture-negative samples.

Conclusions:

  • The developed PCR-based assays are sensitive and specific for the detection of individual Streptococcus pneumoniae serotypes.
  • These molecular assays offer a significant improvement over culture-based methods for identifying pneumococcal serotypes in respiratory specimens.
  • The PCR assays show promise for clinical application in diagnosing pneumococcal infections and understanding colonization patterns.